| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 25mg |
|
||
| 50mg |
|
||
| 100mg |
|
||
| 250mg |
|
||
| 500mg |
|
||
| Other Sizes |
|
| ln Vitro |
ATP generation in mitochondria is regulated by mitochondrial acid 5 (MA-5), which is not influenced by the electron transport chain or oxidative phosphorylation. Increased mitochondrial oxidation and ATP depletion are caused by mitochondrial malfunction and are linked to regeneration in a range of mitochondrial disorders [1]. The plant growth hormone regulator-3-receptor, from which (MA-5) is derived, controls energy stimulation and lowers mitochondrial oxidation to safeguard mitochondrial function. The MTT assay was used to assess cell viability in order to see the protective impact of mitochondrial acid 5 on asteroid cells in controlled conditions. Treatment with TNFα resulted in a considerable reduction in cell viability. Treatment with mitochondrial acid 5 reduces this effect, but, in a dependent way [2].
|
|---|---|
| ln Vivo |
In animal models of cardiac reperfusion injury and cisplatin-induced nephropathy, mitochondrial acid 5 (MA-5) enhances renal function. The study aimed to investigate the protective effects of mitochondrial acid 5 on tissue bioavailability. At a peak time of one hour, mitochondria acid 5 raises the Manhattan concentration in a dose-response manner [1].
|
| References |
|
| Molecular Formula |
C18H13F2NO3
|
|---|---|
| Molecular Weight |
329.297531843185
|
| Exact Mass |
329.086
|
| Elemental Analysis |
C, 65.65; H, 3.98; F, 11.54; N, 4.25; O, 14.58
|
| CAS # |
1354707-41-7
|
| PubChem CID |
76070959
|
| Appearance |
Light yellow to yellow solid powder
|
| LogP |
3.1
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
5
|
| Rotatable Bond Count |
5
|
| Heavy Atom Count |
24
|
| Complexity |
487
|
| Defined Atom Stereocenter Count |
0
|
| InChi Key |
BOKQALWNGNLTOC-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C18H13F2NO3/c19-10-5-6-12(15(20)7-10)17(22)8-13(18(23)24)14-9-21-16-4-2-1-3-11(14)16/h1-7,9,13,21H,8H2,(H,23,24)
|
| Chemical Name |
4-(2,4-difluorophenyl)-2-(1H-indol-3-yl)-4-oxobutanoic acid
|
| Synonyms |
MA 5 MA-5 Mitochonic Acid 5
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ≥ 106.66 mg/mL (~323.90 mM)
H2O : < 0.1 mg/mL |
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (7.59 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (7.59 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (7.59 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.0367 mL | 15.1837 mL | 30.3674 mL | |
| 5 mM | 0.6073 mL | 3.0367 mL | 6.0735 mL | |
| 10 mM | 0.3037 mL | 1.5184 mL | 3.0367 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
